WallStreetZenWallStreetZen

NYSEMKT: CANF
Can Fite Biopharma Ltd Stock Forecast, Predictions & Price Target

Analyst price target for CANF

Based on 1 analyst offering 12 month price targets for Can Fite Biopharma Ltd.
Min Forecast
$18.00+560.55%
Avg Forecast
$18.00+560.55%
Max Forecast
$18.00+560.55%

Should I buy or sell CANF stock?

Based on 1 analyst offering ratings for Can Fite Biopharma Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CANF stock forecasts and price targets.

CANF stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-09

1 of 1

CANF vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CANF$2.73$18.00+560.55%Buy
TCRT$0.70N/AN/A
ELAB$0.58N/AN/A
KPRX$3.72$18.00+383.87%Buy
DOMH$1.90N/AN/A

Can Fite Biopharma Stock Forecast FAQ

Is Can Fite Biopharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSEMKT: CANF) stock is to Buy CANF stock.

Out of 1 analyst, 0 (0%) are recommending CANF as a Strong Buy, 1 (100%) are recommending CANF as a Buy, 0 (0%) are recommending CANF as a Hold, 0 (0%) are recommending CANF as a Sell, and 0 (0%) are recommending CANF as a Strong Sell.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

What is CANF's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CANF price target, the average CANF price target is $18.00, with the highest CANF stock price forecast at $18.00 and the lowest CANF stock price forecast at $18.00.

The Wall Street analyst predicted that Can Fite Biopharma's share price could reach $18.00 by May 9, 2025. The average Can Fite Biopharma stock price prediction forecasts a potential upside of 560.55% from the current CANF share price of $2.73.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.